Detection by screening mammography is a powerful independent predictor of survival in women diagnosed with breast cancer

Breast

Volumn 13, Issue 1, 2004, Pages 15-22

  Gill, P Grantley ^a   Farshid, G ^b   Luke, C G ^c   Roder, D M ^d  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

^c DEPARTMENT OF HUMAN SERVICES   (Australia)

^d CANCER COUNCIL SOUTH AUSTRALIA   (Australia)

Author keywords

Breast cancer; Mammographic detection; Prognosis

Indexed keywords

ANTINEOPLASTIC AGENT; ESTROGEN RECEPTOR; HORMONE;

ADULT; AGED; ARTICLE; AUSTRALIA; BREAST CANCER; CANCER GRADING; CANCER GROWTH; CANCER INVASION; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SYMPTOMATOLOGY; TEACHING HOSPITAL;

EID: 1242342977     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-9776(03)00169-3     Document Type: Article

References (22)

1. South Australian Cancer Registry. Epidemiology of cancer in South Australia. Incidence, mortality and survival, 1977 to 2000. Incidence and mortality, 2000. Adelaide: Openbook Publ., 2001.
2. Australian Institute of Health and Welfare, Australasian Association of Cancer Registries, BreastScreen Australia, National Breast Cancer Centre. Breast cancer size and nodal status. Canberra: AIHW (Cancer Monitoring Series No. 2), October 2001.
3. Gill PG, Roder D. Comparison of breast cancer in women with screen-detected and symptomatic cancer (abstract). Breast 1995;4:254.
4. Spillane AJ, Kennedy CW, Gillett DJ, et al. Screen-detected breast cancer compared to symptomatic presentation: an analysis of surgical treatment and end-points of effective mammographic screening. Aust NZ J Surg 2001;71:398-402.
5. South Australian Cancer Registry. Epidemiology of cancer in South Australia. Incidence, mortality and survival, 1977 to 1995. Incidence and mortality, 1995. Adelaide: Openbook Publ., 1996: p. 113-29.
6. Tabar L, Fagerberg G, Duffy SW, Day NE, Gad A, Grontoft O. Update of the Swedish two-county program of mammographic screening for breast cancer. Radiol Clin North Am 1992;30:187-210.
7. Duffy SW, Tabar L, Fagerberg G, Gad A, Grontoft O, South MC. Breast screening, prognostic factors and survival-results from the Swedish two-county study. Br J Cancer 1991;64:1133-8.
8. South Australian Cancer Registry. Epidemiology of cancer in South Australia. Incidence, mortality and survival, 1977 to 1999. Incidence and mortality, 1999. Adelaide: Openbook Publ., 2000.
9. Skinner KA, Silberman H, Sposto R, Silverstein MJ. Palpable breast cancers are inherently different from nonpalpable breast cancers. Ann Surg Oncol 2001;8:705-10.
10. BreastScreen SA. Statistical report 1998. Adelaide: BreastScreen SA, 2002, p. 23.
11. Fritz A, Percy C, Jack A, et al editors. International classification of diseases for oncology, 3rd ed. Geneva: World Health Organization, 2000.
12. Hahn Johnson C, Richards L, editors. Standards of the commission on cancer, Vol. 2. Registry Operations and Data Standards (ROADS). Chicago: Commission on Cancer, 1998.
13. Blamey RW. The design and clinical use of the Nottingham Prognostic Index in breast cancer. Breast 1996;5:156-7.
14. Reiner A, Numeister B, Spona J, Reiner G, Schemper M, Jakesz R. Immunocytochemical localization of estrogen and progesterone receptor and prognosis in human primary breast cancer. Cancer Res 1990;50:7057-61.
15. Pinder SE, Ellis IO, Galea M, O'Roukes S, Blamey RW, Elston CW. Pathological prognostic factors in breast cancer III. Vascular invasion: relationship with recurrence and survival in a large study with long-term follow-up. Histopathology 1994;24:41-7.
16. Pinder SE, Wencyk P, Sibbering DM, et al. Assessment of the new proliferation marker MIB1 in breast carcinoma using image analysis: association with other prognostic factors and survival. Br J Cancer 1995;71:146-9.
17. Bonett A, Roder D, Esterman A. Cancer case-survival rates for South Australia: a comparison with US rates and a preliminary investigation of time trends. Med J Aust 1988; 148:556-9.
18. STATA Corporation. STATA statistical software. Release 6.0. College Station, TX: STATA Corporation, 1999.
19. South Australian Cancer Registry. Epidemiology of cancer in South Australia. Incidence, mortality and survival, 1977 to 1996. Incidence and mortality, 1996. Adelaide: Openbook Publ., 1997. p. 21-8.
20. South Australian Cancer Registry. Epidemiology of cancer in South Australia. Incidence, mortality and survival, 1977 to 1998. Incidence and mortality, 1998. Adelaide: Openbook Publ., 1999.
21. Gill PG, Birrell SN, Luke CG, Roder DM. Tumour location and prognostic characteristics as determinants of survival of women with invasive breast cancer: South Australian hospital-based cancer registries, 1987 1998. Breast 2002;11:221-7.
22. Funkhouser WK, Kaiser-Rogers K. Review: significance of and optimal screening for her-2 gene amplification and protein overexpression in breast carcinoma. Ann Clin Lab Sci 2001;31:349-58.